The following treatments have been correctly paired with their licensed indication in ophthalmology:
Rationale:
Ranibizumab - age-related macular degeneration. This treatment is specifically indicated for age-related macular degeneration, a leading cause of vision loss, effectively targeting the underlying vascular factors contributing to the condition.
A: Aciclovir - cytomegalovirus (CMV) retinitis. While aciclovir treats certain viral infections, it is not the primary choice for CMV retinitis, which typically requires ganciclovir or foscarnet.
C: Ciprofloxacin - corneal ulceration. Ciprofloxacin is a fluoroquinolone antibiotic effective for bacterial infections but not specifically indicated for the treatment of corneal ulceration, which often requires other therapies.
D: Fusidic acid - hypersensitivity reactions. Fusidic acid is an antibiotic used for skin infections, not for managing hypersensitivity reactions, which involve immune responses rather than bacterial infections.
Acne vulgaris:
Rationale:
Acne vulgaris can be effectively treated with topical benzoyl peroxide. This treatment works by reducing the bacteria on the skin, unclogging pores, and decreasing inflammation, leading to significant improvement in acne symptoms.
B: May be precipitated by oral methylprednisolone. While corticosteroids can affect skin conditions, they are not a direct trigger for acne vulgaris, which is primarily linked to other factors.
C: Is caused by propionibacteria. Propionibacteria contribute to acne development, but they do not solely cause the condition; multiple factors, including hormones and sebum production, play essential roles.
D: Cold tar treatment reduces the severity of lesions. Cold tar is primarily used for psoriasis and other skin conditions, and its efficacy in treating acne vulgaris is not well-supported by clinical evidence.
The following infections/infestations are paired with their appropriate treatment:
Rationale:
Oral aciclovir is the appropriate treatment for initial or recurrent genital herpes simplex. This antiviral medication effectively reduces symptoms and duration of outbreaks, promoting faster healing and minimal discomfort.
A: Topical ketoconazole treats Candida vulvovaginitis, but it is not the first-line treatment for genital herpes, which requires an antiviral approach for effective management.
B: Oral griseofulvin is specifically indicated for fungal nail infections, lacking efficacy against the viral nature of genital herpes simplex, making it unsuitable for this condition.
C: Topical clotrimazole is effective for tinea corporis, a fungal infection, and does not address the viral infection of genital herpes simplex, hence inappropriate for this treatment.
The following are effective in the management of eczema:
Rationale:
Topical betamethasone is effective in the management of eczema. This corticosteroid reduces inflammation and alleviates itching, making it a primary treatment for controlling eczema flare-ups and providing symptomatic relief.
B: Topical alpha-tocopherol lacks sufficient evidence supporting its effectiveness in treating eczema. While it may have some moisturizing properties, it does not address the underlying inflammation associated with the condition.
C: Dithranol primarily serves as a treatment for psoriasis rather than eczema. Its mechanism focuses on reducing skin cell turnover and might aggravate eczema symptoms instead of providing effective relief.
D: Calcipotriol, a vitamin D analog, is mainly used for psoriasis management. Its effectiveness in eczema treatment is minimal and not well-supported, limiting its application for this particular skin condition.
Dilatation of the pupil (mydriasis) is produced by:
Rationale:
C: Atropine produces mydriasis by blocking the action of acetylcholine on the sphincter muscle of the iris, leading to pupil dilation. This anticholinergic effect is crucial for various ophthalmic procedures and treatments.
A: Cyclopentolate primarily serves as a cycloplegic agent, affecting accommodation rather than inducing pupil dilation directly, although it can cause some mydriasis as a secondary effect.
B: Dorzolamide is a carbonic anhydrase inhibitor focused on reducing intraocular pressure in glaucoma, with no significant effect on pupil size or dilation mechanisms.
D: Phenylephrine acts as an alpha-1 adrenergic agonist, causing dilation; however, it is not the primary agent associated with mydriasis in the context given.
The following treatments have been correctly paired with their licensed indication in ophthalmology:
Rationale:
Ranizumab - age-related macular degeneration. This treatment is specifically approved for managing age-related macular degeneration, a leading cause of vision loss, by inhibiting vascular endothelial growth factor and preventing abnormal blood vessel growth in the retina.
A: Aciclovir - cytomegalovirus (CMV) retinitis. Aciclovir is primarily used for herpes infections, not CMV retinitis, which requires different antiviral therapies like ganciclovir for effective management.
C: Ciprofloxacin - corneal ulceration. Ciprofloxacin is an antibiotic effective for bacterial infections but is not specifically indicated for corneal ulceration, where other treatments may be more appropriate.
D: Fusidic acid - hypersensitivity reactions. Fusidic acid is an antibiotic used for bacterial infections, not for treating hypersensitivity reactions, which require entirely different therapeutic approaches.
Acne vulgaris:
Rationale:
Acne vulgaris can be effectively treated with topical benzoyl peroxide. This treatment works by reducing inflammation, unclogging pores, and exerting antibacterial effects on the skin, making it a reliable option for managing acne.
B: May be precipitated by oral methylprednisolone. While steroids can influence skin conditions, they are not a direct cause of acne vulgaris, which is primarily linked to other factors.
C: Is caused by propionibacteria. Although propionibacteria are associated with acne, they are not the sole cause; hormonal factors and excess sebum production play significant roles in acne vulgaris development.
D: Cold tar treatment reduces the severity of lesions. Cold tar is typically used for psoriasis and other conditions, not acne vulgaris; thus, it does not effectively target the underlying issues of acne lesions.
The following infections/infestations are paired with their appropriate treatment:
Rationale:
Initial or recurrent genital herpes simplex - oral aciclovir. This treatment effectively targets herpes simplex virus outbreaks, reducing symptoms and preventing the spread of the infection, making it the appropriate choice for managing genital herpes.
A: Candida vulvovaginitis - topical ketoconazole. This antifungal treatment is not primarily indicated for Candida vulvovaginitis, as over-the-counter options like clotrimazole are typically preferred for this condition.
B: Fungal nail infections - oral griseofulvin. Although effective for dermatophyte infections, griseofulvin is not the first-line treatment for fungal nail infections, which are often better managed with terbinafine or itraconazole.
C: Tinea corporis - topical clotrimazole. While clotrimazole can treat fungal skin infections, it is not the best choice for tinea corporis, where other topical antifungals may provide more effective results.
The following are effective in the management of eczema:
Rationale:
Topical betamethasone is effective in the management of eczema. This corticosteroid reduces inflammation, alleviates itching, and promotes healing in affected skin areas, making it a standard treatment choice for eczema patients.
B: Topical alpha-tocopherol does not address inflammation or itching specifically linked to eczema, which limits its efficacy as a primary treatment option for managing the condition.
C: Dithranol is typically used for psoriasis treatment rather than eczema, making it unsuitable for addressing the specific symptoms and skin reactions associated with eczema management.
D: Calcipotriol, predominantly used for psoriasis, does not effectively treat eczema symptoms and may not provide the necessary relief for patients suffering from this specific skin condition.
Dilatation of the pupil (mydriasis) is produced by:
Rationale:
Mydriasis is produced by Atropine. Atropine is an anticholinergic agent that inhibits the action of acetylcholine on the sphincter muscle of the iris, leading to pupil dilation. This effect is utilized in various ophthalmic procedures.
A: Cyclopentolate This medication also dilates pupils but primarily functions as a cycloplegic agent, affecting accommodation rather than direct mydriasis, making it less effective for this purpose.
B: Dorzolamide This carbonic anhydrase inhibitor is primarily used to lower intraocular pressure in glaucoma; it does not induce pupil dilation and has no mydriatic properties.
D: Phenylephrine While Phenylephrine can cause mydriasis, it primarily acts as an alpha-1 adrenergic agonist, not an anticholinergic, differentiating it from the direct action of Atropine.